Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hotspot TERT promoter mutations are rare events in testicular germ cell tumors.
Cárcano FM, Vidal DO, van Helvoort Lengert A, Neto CS, Queiroz L, Marques H, Baltazar F, da Silva Martinelli CM, Soares P, da Silva EC, Lopes LF, Reis RM. Cárcano FM, et al. Among authors: van helvoort lengert a. Tumour Biol. 2016 Apr;37(4):4901-7. doi: 10.1007/s13277-015-4317-y. Epub 2015 Nov 3. Tumour Biol. 2016. PMID: 26526580
MicroRNA‑130a‑3p inhibition suppresses cervical cancer cell progression.
Causin RL, Van Helvoort Lengert A, Gomes INF, De Freitas AJA, Rosa MN, Dos Reis R, Reis RM, Marques MMC. Causin RL, et al. Among authors: van helvoort lengert a. Oncol Rep. 2023 May;49(5):109. doi: 10.3892/or.2023.8546. Epub 2023 Apr 13. Oncol Rep. 2023. PMID: 37052265 Free PMC article.
DNA methylation patterns suggest the involvement of DNMT3B and TET1 in osteosarcoma development.
Pires SF, de Barros JS, da Costa SS, de Oliveira Scliar M, Van Helvoort Lengert A, Boldrini É, da Silva SRM, Tasic L, Vidal DO, Krepischi ACV, Maschietto M. Pires SF, et al. Among authors: van helvoort lengert a. Mol Genet Genomics. 2023 May;298(3):721-733. doi: 10.1007/s00438-023-02010-8. Epub 2023 Apr 5. Mol Genet Genomics. 2023. PMID: 37020053
Insights in Osteosarcoma by Proton Nuclear Magnetic Resonance Serum Metabonomics.
Quintero Escobar M, Costa TBBC, Martins LG, Costa SS, vanHelvoort Lengert A, Boldrini É, Morini da Silva SR, Lopes LF, Vidal DO, Krepischi ACV, Maschietto M, Tasic L. Quintero Escobar M, et al. Front Oncol. 2020 Oct 16;10:506959. doi: 10.3389/fonc.2020.506959. eCollection 2020. Front Oncol. 2020. PMID: 33178572 Free PMC article.
RAD50 Deficient in a Breast Cancer Model Predicts Sensitivity to PARP Inhibitors.
Ramos CRN, Oliveira RJS, Rosa MN, Pereira AS, de Abreu RBV, van Helvoort Lengert A, Reis RM, Silva VAO, Palmero EI, Melendez ME. Ramos CRN, et al. Among authors: van helvoort lengert a. Curr Cancer Drug Targets. 2023;23(11):900-909. doi: 10.2174/1568009623666230418101511. Curr Cancer Drug Targets. 2023. PMID: 37076963